Incidence of Hepatitis B and C Infections in Patients of Mental Disorders

Year 2017, Volume: 44 Issue: 1, 51 - 55, 17.03.2017

Suleyman Donmezdil Murat Yalcin Hakan Temiz

https://doi.org/10.5798/dicletip.298596

Cited By: 1

Abstract

Ojective: It is estimated that Hepatitis B (HBV) and Hepatitis C (HCV) diseases have high morbidity, affecting more than 400 million people in the world. Turkey is considered as a semi-pandemic region for these infections.
Methods: In this study, our aim is to determine the seroprevalance of HBV and HCV in psychiatric hospitalized patients which is thought to be the risk group and to support the literature in terms of protective precautions in the progressed stages. Our study was performed between February-2014 and January 2015 in Diyarbakır Selahaddin Eyyubi State Hospital psychiatry clinic. The patient’s files were investigated retrospectively, the results of serological tests (HBsAg, AntiHBS and AntiHCV) and socio-demographical data (age, sex, diagnoses and living areas) were used.
Results: HBSAg positivity was 1.7% in schizophrenia patients, 0,8% in bipolar affective disorder patients, 0.4% in retarded patients and 0,3% in depression patients. A statistically significant relationship was found between schizophrenia and HBSAg.
Conclusion: Similar precautions against viral hepatitis with high transmission rates should be applied in the chronic, disabled psychiatric patients just like the normal population. Active immunization will be useful in the schizophrenia group patients having relatively more risk. Extensive studies should be performed to obtain detailed and accurate data.

Keywords

Mental Disorders, Hepatitis B

References

• 1. Johnson DF, Leder K, Torresi J. Hepatitis B and C infection in international travelers. J Travel Med. 2013 May-Jun;20:194-202. doi: 10.1111/jtm.12026. Epub 2013 Apr 4. Review. PubMed PMID: 23577866.
• 2. Akhan S. Kronik Hepatit B Virusu İnfeksiyonunun Yönetimi Klimik Dergisi 2014;27(Özel Sayı 1):2-18.
• 3. Akarca US. Chronic hepatitis B. A guideline to diagnosis, approach, management, and follow up 2007. Turkish Association for the Study of Liver. Turk J Gastroenterol 2008;19:207-30.
• 4. Balık D, Üstüner I, et al. Rize bölgesinde yaşayan gebe kadınlarda HBsAg, AntiHBs ve Anti-HCV seroprevalansı Dicle Medical Journal. 2013;40:254-7.
• 5. Öncül A, Aslan S, Pirinççioğlu H, Özbek E. Determination of HBV, HCV, HIV, VDRL seropositivity and vaccination rates in Diyarbakır State Hospital workers Deneysel ve Klinik Tıp Dergisi - Journal of Experimental and Clinical Medicine 29;2012:280-4.
• 6. Değertekin H, Yalçın K, Yakut M, Yurdaydın C. Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey:a meta-analysis. Liver Int. 2008;28: 494-8. doi: 10.1111/j.1478-3231.2008.01673.x.
• 7. Değertekin B. Hepatit B patogenezi, doğal seyri ve kliniği. Türkiye Klinikleri Gastroenterohepatoloji Özel Dergisi. 2010;3:45-52.
• 8. Campos LN, Guimarães MD, Carmo RA, et al. HIV, syphilis, and hepatitis B and C prevalence among patients with mental illness: a review of the literature. Cad Saude Publica. 2008;24 Suppl 4:s607-20. Review. PubMed PMID: 18797734.
• 9. Ulmer T, Schmidt. Almanya’da Hepatit B ile daha iyi mücadele için tavsiyeler. “Avrupa’da Hepatit B ile daha iyi Mücadele için Avrupa Uyum Çalışmaları”nın Geliştirilmesi. S 2008 (Çeviri).
• 10. Chaudhury S, Chandra S, Augustine M. Prevalence of Australia antigen (HBsAg)in institutionalised patients with psychosis. Br J Psychiatry. 1994 Apr;164:542-3. PubMed PMID: 8038945.
• 11. Çetinkol Y, Yıldırım AA. The Seroprevalence of Viral Hepatitis A in Patiens Who Had Been Consulted at Ünye State Hospital. Kocatepe Tıp Dergisi. 2011;12:18-22.
• 12. Hepatitis B. World Health Organization. http://www.who.int/ mediacentre/factsheets
• 13. Cividini A, Pistorio A, Regazzetti A, et al. Hepatitis C virüs infection among institutionalised psychiatric patients: a regression analysis of indicators of risk. J Hepatol. 1997 Sep;27:455-63. PubMed PMID: 9314121.
• 14. Carmo RA, Campos LN, Melo AP, Guimarães MD. Hepatitis C among patients with mental illness in Brazil: an analysis of associatedfactors. Gen Hosp Psychiatry. 2013 Mar-Apr;35:129-33.
• 15. Polat S.A. The Seroprevalence of B and C Hepatitis in Hospitalized Psychiatric Patients C. Ü. Tıp Fakültesi Dergisi 24:15–20, 2002.
• 16. Sezak N, Tosun S, Eriş N, Ayer A. Prevalence of Hepatitis B and Hepatitis C Infections and Evaluation of Related Factors in Patients in a Mental Health Hospital Klimik Dergisi 2011;24:154-7.
• 17. Dinwiddie SH, Shicker L, Newman T. Prevalence of hepatitis C among psychiatric patients in the public sector. Am J Psychiatry. 2003 Jan;160:172-4. PubMed PMID: 12505819.
• 18. Durotoye IA, Issa BA, Fadeyi A, et al.; DaudaSulyman. Sero-prevalence of hepatitis B and C among mentally ill patients attending a tertiary hospital in Nigeria. Ann Afr Med. 2014 Oct-Dec;13:210-6. doi: 10.4103/1596-3519.142293. PubMed PMID:25287036.
• 19. Blanchard JJ, Horan WP, Collins LM. Examining the latent structure of negative symptoms: is there a distinct subtype of negative symptom schizophrenia? Schizophr Res. Sep 15.2005;77:151-65.
• 20. TC Sağlık Bakanlığı Temel Sağlık Hizmetleri İstatistik Yıllıkları, Çalışma Yıllığı 2006 http://www.saglik.gov.tr